Fig. 1: Overall survival stratified by R2-ISS in newly diagnosed patients.

A OS for the entire cohort of 2929 with available data, B transplant eligible patients from time of high-dose therapy (HDT), C younger tranplant ineligible patients, and D older tranplant ineligible patients. Median overall survival and C-index indicated.